Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)

NCT00378599 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation
Hepatitis C, Chronic
Liver Cirrhosis

Interventions

DRUG: Combination of (a) pegylated interferon alfa-2b and (b) rebetol

Sponsor

Merck Sharp & Dohme LLC